Alnylam Pharmaceuticals (ALNY) Asset Utilization Ratio (2010 - 2026)
Alnylam Pharmaceuticals' Asset Utilization Ratio was 0.90 in Q2 2026, up 107.9% from 0.43 a year earlier and up 5.9% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Alnylam Pharmaceuticals came in at 0.81, up 44.8% from FY2024.
- Asset Utilization Ratio has now increased for seven consecutive years.
- In earlier years, Asset Utilization Ratio was 0.56 in FY2024 (+12.4%), 0.50 in FY2023 (+71.8%), 0.29 in FY2022 (+20.5%) and 0.24 in FY2021 (+41.0%).
- The Q2 2026 figure marks the highest quarterly Asset Utilization Ratio in data going back to Q3 2010.
- Compared with a year earlier, Asset Utilization Ratio has increased for four straight quarters, with growth averaging 26.4% over the last eight quarters.
- The best year-over-year quarter for Asset Utilization Ratio over five years was Q2 2026 (growth of 107.9%); the worst was Q2 2025 (a decline of 27.8%).
- Per Business Quant data, ALNY's Asset Utilization Ratio in the three quarters before Q2 2026 was 0.85 (Q1 2026), 0.64 (Q4 2025) and 0.56 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | Alnylam Pharmaceuticals | 33.00 Bn | 21.05 Bn | 992.69 Mn | 0.90 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.90 |
| Mar 31, 2026 | 0.85 |
| Dec 31, 2025 | 0.76 |
| Sep 30, 2025 | 0.66 |
| Jun 30, 2025 | 0.58 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.51 |
| Jun 30, 2024 | 0.60 |
| Mar 31, 2024 | 0.52 |
| Dec 31, 2023 | 0.48 |
| Sep 30, 2023 | 0.48 |
| Jun 30, 2023 | 0.36 |
| Mar 31, 2023 | 0.33 |
| Dec 31, 2022 | 0.29 |
| Sep 30, 2022 | 0.28 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.25 |
| Dec 31, 2021 | 0.24 |
| Sep 30, 2021 | 0.21 |
| Jun 30, 2021 | 0.20 |
API Access
Alnylam Pharmaceuticals Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();